Cardiff Oncology (CRDF) Short term Debt (2013 - 2018)

Cardiff Oncology has reported Short term Debt for 6 years, with the latest figure at $1.2 million in Q1 2018.

• Quarterly Short term Debt fell 69.67% year-over-year to $1.2 million in Q1 2018, while the trailing twelve-month figure through Mar 2018 was $1.2 million (down 69.67% YoY) and the FY2017 annual result came in at $1.3 million, down 43.58% from the prior year.
• Short term Debt retreated to $1.2 million in Q1 2018 per CRDF's latest filing, from $1.3 million in the prior quarter.
• Over five years, Short term Debt peaked at $6.1 million in Q2 2016 and troughed at $200792.0 in Q1 2014.
• A 5-year average of $2.6 million and a median of $2.1 million in 2014 frame the typical range for Short term Debt.
• The sharpest annual moves came in 2015 and 2016: Short term Debt jumped 1426.32% in 2015, then slumped 78.61% in 2016.
• Over 5 years, Short term Debt stood at $1.9 million in 2014, then surged by 175.25% to $5.2 million in 2015, then tumbled by 54.84% to $2.4 million in 2016, then tumbled by 43.58% to $1.3 million in 2017, then declined by 11.76% to $1.2 million in 2018.
• According to Business Quant data, Short term Debt over the past three periods registered $1.2 million, $1.3 million, and $1.5 million for Q1 2018, Q4 2017, and Q3 2017 respectively.